Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 41
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

NOVUGEN

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 37
  • 0 comments

FDA approve LENALIDOMIDE

Comment Full text

ZHEJIANG POLY PHARM

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 40
  • 0 comments

FDA approve AMIODARONE HYDROCHLORIDE

Comment Full text

BAYER

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 42
  • 0 comments

FDA approve NAPROXEN SODIUM

Comment Full text

PRINSTON INC

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 36
  • 0 comments

FDA approve BUSULFAN

Comment Full text

UNICHEM

  • FDA Approval
  • Sept. 13, 2024, 08:48 UTC
  • 38
  • 0 comments

FDA approve CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Comment Full text

SOMERSET

  • FDA Approval
  • Sept. 12, 2024, 04:27 UTC
  • 33
  • 0 comments

FDA approve BRIMONIDINE TARTRATE; TIMOLOL MALEATE

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 41
  • 0 comments

FDA approve DEXMETHYLPHENIDATE HYDROCHLORIDE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 39
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

BAXTER HLTHCARE CORP

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 42
  • 0 comments

FDA approve CIPROFLOXACIN

Comment Full text
  • Previous
  • 312
  • 313
  • 314
  • 315
  • 316
  • Next

Search

News categories

  • Technical Exchange News(10611)
  • Event(2032)
  • SEC News(185159)
  • FDA Approval(9858)
  • Company Report(721)
  • Business News(122567)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin